Sunshine Act Requires Reporting All Payments to Physicians

by Jackson Walker
Contact

Beginning August 1, 2013, manufacturers of Medicare or Medicaid covered drugs, medical devices, biologicals and medical supplies must collect and make publicly available data on physicians and teaching hospitals with whom the manufacturer has a financial relationship. The reports will include confidential information such as the name and address of the recipient of the payments, as well as the amount of the payments.

The Physician Payment Sunshine Act (the "Act") requires applicable manufacturers of drugs, devices, biologicals, or medical supplies covered by Medicare, Medicaid or the Children's Health Insurance Program ("CHIP") to annually report payments or transfers of value provided directly to physicians and teaching hospitals. In addition, applicable manufacturers and applicable group purchasing organizations ("GPOs") are required to annually report physician ownership or investment interests and the ownership or investment interests of a physician's immediate family member. Reported information will be published online.
The Meaning of It All
Applicable Manufacturer - An "applicable manufacturer" is an entity that is either (i) engaged in the production, preparation, propagation, compounding, or conversion of a covered drug, device, biological, or medical supply for sale or distribution in the United States, or in a territory, possession, or commonwealth of the United States; or (ii) under common ownership with such an entity, and which provides assistance or support to such entity with respect to the production, preparation, propagation, compounding, conversion, marketing, promotion, sale, or distribution of a covered drug, device, biological, or medical supply for sale or distribution in the United States, or in a territory, possession, or commonwealth of the United States.
Somewhat surprisingly, some distributors and wholesalers (including repackagers, relabelers, and kit assemblers) constitute "applicable manufacturers" for the purpose of the Act's reporting requirements. In response to comments about whether distributors and wholesalers should be subject to the reporting requirements, CMS reasoned that those distributors that hold the title to a covered product are similar to applicable manufacturers since both hold title to the product at some point in the production and distribution cycle. Accordingly, CMS has clarified that distributors and wholesalers that ever hold the title to a covered drug, device, biological or medical supply meet the definition of "applicable manufacturer," meaning that these entities are subject to the Act's reporting requirements.
Drugs, Devices, Biologicals, or Medical Supplies - The Act defines covered drugs, devices, biologicals or medical supplies as any drugs, devices, biological,  or medical supplies for which payment is available under Medicare, Medicaid or CHIP, either separately (such as through a fee schedule) or as part of a bundled payment (for example, under the hospital inpatient prospective payment system); provided that only those drugs and biologicals requiring a prescription to be dispensed are included, and only those devices (including medical supplies which are devices) requiring premarket approval by or premarket notification to the FDA are included.
CMS has clarified that raw materials and components often do not meet this definition because payment is not available for them in their component form under Medicare, Medicaid or CHIP. Accordingly, entities that only manufacture raw materials or components, which are not themselves covered products, will not be required to report unless they are under common ownership with an applicable manufacturer and assist such manufacturer with the production, preparation, propagation, compounding, conversion, marketing, promotion, sale, or distribution of a covered drug, device, biological, or medical supply.
Covered Recipients - The Act uses the term "covered recipients" to refer to physicians and teaching hospitals, and applicable manufacturers should take note the term "physician" encompasses more than just doctors of medicine. Specifically, the Act adopts the Medicare definition of the term "physician," which includes doctors of medicine, doctors of osteopathy (including osteopathic practitioners), doctors of dental surgery or dental medicine, doctors of podiatric medicine, doctors of optometry, and chiropractors.
Content of Reports
Reports of Payments or Transfers of Value - The annual reports regarding payments or transfers of value must contain all of the following information for each payment or transfer of value: (i) name of covered recipient; (ii) address of covered recipient; (iii) in the case of physician recipients, identifiers including specialty, National Provider Identifier, and state professional license numbers; (iv) amount of payment or other transfer of value; (v) date of payment or other transfer of value; (vi) form of payment or other transfer of value; (vii) nature of payment or other transfer of value; (viii) related covered drug, device, biological or medical supply, if applicable; (ix) eligibility for delayed publication; (x) in some cases of payments to third parties, the recipient name; (xi) payments or transfers of value to physician owners or investors or their immediate family members; and (xii) if desired, additional clarifying information.
Applicable manufacturers should also note that there are special rules for reporting payments or other transfers of value made in connection with research activities, continuing education programs, and food and beverage expenses. In addition, certain payments and transfers of value are specifically excluded from the reporting requirements. These include, but are not limited to: (i) indirect payments or transfers where the applicable manufacturer is unaware of the identity of the covered recipient; (ii) for CY 2013, payments or transfers of value less than $10 and not aggregating to more than $100; (iii) product samples intended for patient use and not intended for sale; and (iv) certain educational materials and items that directly benefit patients.
Reports of Physician Ownership and Investment Interests - The annual reports regarding physician ownership and investment interests must contain the following information: (i) name of physician and an indication of whether the ownership or investment interest is held by the physician or an immediate family member; (ii) primary business address of physician; (iii) identifiers including specialty, National Provider Identifier, and state professional license numbers; (iv) dollar amount invested by each physician or immediate family member; and (v) value and terms of each ownership or investment interest.
For the purposes of the Act, an immediate family member is any of the following: (i) a spouse; (ii) a natural or adoptive parent, child, or sibling; (iii) a stepparent, stepchild, stepbrother, or stepsister; (iv) a father-, mother-, daughter-, son-, brother-, or sister-in-law; (v) a grandparent or grandchild; or (vi) a spouse of a grandparent or grandchild.
Timing and Procedural Considerations
Data collection must begin on August 1, 2013, and the data for CY 2013 must be reported to CMS by March 31, 2014. All subsequent reports must be submitted by the 90th day of the calendar year.  The procedures for submitting reports are set forth in the final rule. They require, among other things, that applicable manufacturers register with CMS within ninety days of the end of the calendar year for which a report is required.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Jackson Walker | Attorney Advertising

Written by:

Jackson Walker
Contact
more
less

Jackson Walker on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Privacy Policy (Updated: October 8, 2015):
hide

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

Information Collection and Use by JD Supra

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Email Choice/Opt-out

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.

Security

JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at info@jdsupra.com. In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Sharing and Disclosure of Information JD Supra Collects

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

Links to Other Websites

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

Changes in Our Privacy Policy

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

Contacting JD Supra

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at: info@jdsupra.com.

- hide
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.